Chinese Drug Regulator Accepts Jilin Province Xidian Pharma's Application to Change Alzheimer Drug's Authorization Holder; Shares Down 3%
Chinese Drug Regulator Accepts Jilin Province Xidian Pharma's Application to Change Alzheimer Drug's Authorization Holder; Shares Down 3%
中国药品监管机构接受亚联发展省西电制药申请,变更阿尔茨海默病药物授权持有人;股价下跌3%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册